Activity Description & Educational Objectives
This educational activity based on a recent live symposium held in conjunction with the Fifth Cooperative Meeting of the Consortium of MS Centers (CMSC) and the Americas Committee for Treatment and Research in MS (ACTRIMS) is designed to increase the knowledge and competence of neurologists with respect to the management of multiple sclerosis. In this activity, Dr. Timothy Vollmer and Dr. John Corboy will discuss several interesting areas related to the management of MS including recent data on available and emerging disease-modifying therapies and the current status of predictive and prognostic biomarkers for patients with this disease. They will also discuss the science behind the comprehensive treatment of MS.
Upon completion of this activity, participants should be better able to:
Apply key efficacy, safety, and tolerability data on established disease-modifying therapies (DMTs) in the management of MS
Analyze how emerging DMTs might best be utilized in patients with MS
Assess the potential utility of established and emerging biomarkers in patients with MS
Review and discuss emerging science supporting the comprehensive management of patients with MS
